New insulin boosts artificial pancreas performance in type 1 diabetes trial
Disease control
Completed
This study tested a faster-acting insulin (Lyumjev) in an artificial pancreas system for people with type 1 diabetes. Twelve adults who already used the artificial pancreas took part. The goal was to see if the new insulin kept blood sugar in a healthy range better than the stand…
Phase: NA • Sponsor: Inreda Diabetic B.V. • Aim: Disease control
Last updated May 26, 2026 11:52 UTC